(Q42909159)

10 November 2017

American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section (English)

1 reference

10 November 2017

1 reference

Patrick Y Wen

1

1 reference

10 November 2017

1 September 2010

1 reference

Expert Review of Anticancer Therapy

10 November 2017

1 reference

10 November 2017

10

1 reference

10 November 2017

9

1 reference

10 November 2017

1367-1369

1 reference

Antiangiogenic therapies for high-grade glioma

10 November 2017

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

What role should cilengitide have in the treatment of glioblastoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.117

21 January 2018

Identifiers

DOI

10.1586/ERA.10.117

1 reference

10 November 2017

1 reference

PubMed ID

20836670